Breast cancers with the common ERBB2 amplification defining the HER2-positive subset have only partially overlapping amplifications with CTCFL suggesting that the two amplicons may be created by different underlying mechanisms and not by a common mechanism affecting the two chromosomes, 17 and 20. The gene discussed is ERBB2; the disease is breast cancer.